AFYA

BuyUnloved Quality

Afya Limited · Consumer Defensive · Brazil · $1.2B cap · $6.7M/day traded

$14.85 +0.7% · close 12 Oct · scored 14 Oct

StockRank down 3.5 since 13 Oct: Momentum down 3.

Unloved Quality: Strong and cheap; the market has not turned yet.

76
StockRank
Get score and insider alerts

Report expected 12 Nov: the next-year EPS estimate has fallen 0.9% over the last 13 weeks.

Quality
68
Value
55
Momentum
48

As of 14 Oct 2026, MoatMap's StockRank for Afya Limited (AFYA) is 76/100, ranked against 24,000+ stocks in 35 markets (Quality 68, Value 55, Momentum 48, each scored against its sector).

Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →

P/E (TTM)
9.0x
peers 14.2x
ROE
16.7%
peers 7.8%
D/E
0.6x
peers 0.7x
Dividend %
4.4%
trailing yield

ABOUT AFYA LIMITED

Read

Afya Limited is a leading medical education group in Brazil, offering undergraduate and graduate courses in medicine, health sciences, and related fields. It benefits from high demand for medical professionals in Brazil, a large and integrated network of institutions, and a strong digital platform. Afya is a dominant and rapidly expanding player in the private medical education market in Brazil.

FINANCIAL SUMMARY (USD)

Year20212022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue1.7B467.8M577.6M663.7M742.6M-18.9%768.8M799.5M855.9M7.4%
EPS2.390.830.861.411.67-8.6%1.641.581.752.4%
Shares93.7M89.9M89.9M90.3M89.9M-4.1%————
Debt2.2B545.2M537.3M637.4M626.6M-26.6%626.5M———
Equity2.9B642.5M723.3M857.6M974.5M-24.2%————
Op CF630.9M169.5M209.6M287.7M307.6M-16.4%313.0M———
Inv CF-1.3B-118.8M-229.6M-219.2M-101.8M—————
Fin CF364.7M18.7M-88.4M4.8M-162.3M—————
Loading 1Y...
PRICE (1Y) · USD+1.7%
11.812.613.414.114.931 Aug22 Sep12 Oct
SMA 50SMA 200

Price checkStill fallingExperimental

Made a new 52-week low 9 trading days ago, 8% below its 52-week high. The fall has not stopped yet.

SwingsAverage

Calmer than 71% of stocks we rank over the past year (31% a year).

How this is worked out

StockRank judges the business. The price check reads only the chart: it is the price side of the Momentum score, in words.

The rules: Still falling is a new 52-week low in the last two weeks, at least 25% below the high. Finding a floor is no new low since. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average and within 15% of the high.

In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn like this one cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.

What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.

What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.

Calm is not safe: a calm stock can still slide steadily.

Rules fixed before any data was fetched. Describes the chart, not a recommendation.

Close
$14.85
RSI (14)
63.1
52-Week Range-8.1% from high
Low $11.62High $16.16

SCORE BREAKDOWN

Quality
68
ROIC
16.1%73.5
ROE
16.7%76.6
GP/Assets
27.5%50.3
Op. Margin
30.6%95.5
FCF/Assets
13.5%89.1
Piotroski
889.6
Int. Cover
2.9x25.3
D/E Ratio
0.63x35.1
Current Ratio
2.20x68.3
Value
55
P/E (TTM)
9.0x84.9
EV/EBITDA
11.5x37.1
P/FCF
5.0x85.1
P/B
6.9x9.2
P/S
1.7x32.1
Div Yield
4.4%73.4
Momentum
48
52W High %
92%81.4
RS 6M
-19%41.3
SMA 50/200
0.98x45.3
EPS Rev 4W
-2.5%8.0
EPS Rev 12W
-0.9%30.2
EPS Improve
+19%39.2
Q Growth
14%58.8

FUNDAMENTALS

Market Cap
$1.2B
P/E (Forward)
7.5x
Gross Margin
64.0%

SECTOR PEERS

Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of AFYA are excluded.

TickerCompanyMkt CapStockRankSignal
AFYAAfya Limited(you)$1.2B76Buy
COGN3.SACogna Educação S.A.$893M65Buy
YDUQ3.SAYduqs Participações S.A.$535M84Strong Buy
VTRU3.SAVitru Educação S.A.$437M96Strong Buy
CSED3.SACruzeiro do Sul Educacional S.A.$378M97Strong Buy
SEER3.SASer Educacional S.A.$347M98Strong Buy
ANIM3.SAÂnima Holding S.A.$219M90Strong Buy
OBTC3.SAOranjebtc S.A. - Educação e Investimento$198M14Strong Sell
MDIA3.SAM. Dias Branco S.A. Indústria e Comércio de Alimentos$1.1B58Hold
SLCE3.SASLC Agrícola S.A.$1.7B63Hold

Peer medians: ROE 7.8% · P/E 14.2x · Gross margin 50.8%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

Afya Limited (AFYA): Stock Score Summary

Afya Limited (AFYA) has a MoatMap StockRank of 76/100 based on Quality (68/100), Value (55/100), and Momentum (48/100) factor scores. The current signal is BUY.

Afya Limited is a leading medical education group in Brazil, offering undergraduate and graduate courses in medicine, health sciences, and related fields. It benefits from high demand for medical professionals in Brazil, a large and integrated network of institutions, and a strong digital platform. Afya is a dominant and rapidly expanding player in the private medical education market in Brazil.

Key Financial Metrics

Price$14.85
Market Cap$1.2B
P/E (TTM)8.99
P/E (Forward)7.54
Price/Book6.94
Return on Equity16.7%
Return on Invested Capital16.1%
Debt/Equity0.63x
Gross Margin64.0%
Operating Margin30.6%
Revenue Growth5.7%
Dividend Yield4.4%
Free Cash Flow$241M

Afya Limited operates in the Education & Training Services industry, part of the Consumer Defensive sector (Brazil).

Frequently Asked Questions

What is Afya Limited’s (AFYA) StockRank?
MoatMap’s StockRank for Afya Limited (AFYA) is 76/100, with a Buy signal. It is a composite of Quality (68), Value (55), and Momentum (48), each scored against its sector. The composite is then ranked across MoatMap’s universe of 24,000+ stocks.
Does Afya Limited have an economic moat?
Afya Limited (AFYA) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Afya Limited a buy, hold, or sell?
MoatMap’s current signal for Afya Limited (AFYA) is Buy, based on a StockRank of 76/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Afya Limited in?
Afya Limited (AFYA) operates in the Consumer Defensive sector, specifically the Education & Training Services industry (Brazil).